MTSR
Metsera Inc

503
Mkt Cap
$5.57B
Volume
361,297.00
52W High
$54.47
52W Low
$12.30
Price
$52.98
MTSR Fundamentals
Prev Close
$52.95
Open
$52.79
50D MA
$42.18
Beta
1.94
Avg. Volume
3.42M
EPS (Annual)
-$1.99
P/B
12.37
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Halper Sadeh LLC Investigates FSFG, MTSR, VRNT, MRUS on Behalf of Shareholders
Halper Sadeh LLC Investigates FSFG, MTSR, VRNT, MRUS on Behalf of Shareholders Halper Sadeh LLC Investigates FSFG, MTSR, VRNT, MRUS on Behalf of Shareholders PR Newswire NEW YORK, Oct. 21, 2025 NEW...
PR Newswire·5h ago
News Placeholder
More News
News Placeholder
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate Merger - FSFG, MTSR, VRNT, and MRUS
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate Merger - FSFG, MTSR, VRNT, and MRUS $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate Merger - FSFG, MTSR...
PR Newswire·9h ago
News Placeholder
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates UNP, MTSR, SCS on Behalf of Shareholders
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates UNP, MTSR, SCS on Behalf of Shareholders SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates UNP, MTSR, SCS on Behalf of Shareholders PR...
PR Newswire·13d ago
News Placeholder
Viking Therapeutics Ignites Retail-Trader Frenzy Amid Deal Speculation, Upcoming Trial Catalysts
Shares rose nearly 4% overnight as investors tied Viking’s upcoming trial and its positioning to renewed obesity-drug deal momentum after Pfizer’s Metsera buyout.
Stocktwits·16d ago
News Placeholder
Can PFE Successfully Return to the Obesity Space With Metsera Buyout?
Pfizer strikes a $4.9B deal for Metsera, adding obesity drug candidates to its pipeline after scrapping danuglipron.
Zacks·29d ago
News Placeholder
Company News for Sep 23, 2025
Companies In The News Are: ORCL, TAP, AAPL, MTSR, PFE.
Zacks·29d ago
News Placeholder
Viking Therapeutics Stock Gets Boost From Pfizer-Metsera Deal, Says BTIG — Retail Slams Rivals For Buying ‘Inferior Pipelines’
BTIG said Pfizer’s $7.3 billion Metsera acquisition sharpens its clinical updates and strategic optionality.
Stocktwits·29d ago
News Placeholder
Nvidia, Metsera, Oracle, Apple, Compass: Stocks Making The Biggest Moves Today
Nvidia’s shares were up nearly 4% in Monday’s afternoon session, hitting an all-time high, after the company announced that it will invest up to $100 billion in OpenAI as part of a new partnership with the AI startup.
Stocktwits·30d ago
News Placeholder
Metsera Stock Surges 59% Pre-Market After Pfizer Confirms Acquisition – Here Are The Details
The upfront purchase price of $47.50 per share implies a premium of 43% from Metsera’s closing share price on Friday.
Stocktwits·30d ago
News Placeholder
Pfizer Stock Draws Focus On Report Of $7.3B Deal Plan For Metsera Buyout As Obesity Drug Race With Lilly, Novo Heats Up
Pfizer is pushing into the booming weight-loss market after its own drug setback, as rivals Eli Lilly and Novo Nordisk lead the field.
Stocktwits·1mo ago

Latest MTSR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.